12). Early studies mapping TPO autoantibody epitopes with murine monoclonal (3-Carboxypropyl)trimethylammonium chloride antibodies established that autoantibodies Fgd5 recognize a restricted region about TPO (16). with this Perspective, we will focus on human being disease, which, although more difficult to study than animal models, is likely to generate information more relevant to human being pathology. Autoantigens in autoimmune thyroid disease The study of HT and GD has been facilitated from the recognition, molecular cloning, and manifestation of dominating and specific target antigens, thyroid peroxidase (TPO; examined in ref. 2) and the thyrotropin receptor (TSHR; examined in ref. 3). TPO, the primary enzyme involved in thyroid hormonogenesis, was initially recognized in 1959 as the thyroid microsomal antigen. As discussed below, it is uncertain whether TPO autoantibodies or TPO-specific T cells are the primary cause of thyroid inflammation, which can lead, in some individuals, to thyroid failure and hypothyroidism. On the other (3-Carboxypropyl)trimethylammonium chloride hand, GD is unquestionably caused by a humoral response to the TSHR. Autoantibodies mimic the action of the ligand TSH, therefore activating the TSHR and directly causing hyperthyroidism. The autoimmune response to thyroglobulin, probably the most abundant thyroid protein, appears to perform a lesser part in human being thyroid autoimmunity than in animal models of thyroiditis. Similarly, although the recent molecular cloning of the thyroid sodium-iodide symporter (4) has created a flurry of interest in its potential part as an autoantigen, growing evidence does not support this probability. The molecular cloning of TPO led to the amazing realization that this enzyme is definitely a cell surface protein (examined in ref. 2). TPO is definitely a 107-kDa, 933?amino acid residue glycoprotein with a single membrane-spanning section and is present like a dimer within the apical surface of the thyroid follicular cell. A stop codon introduced in the TPO ectodomain?plasma membrane junction converts the 933?amino acid membrane-associated molecule into an 845-residue secreted protein that can be purified in milligram amounts from medium conditioned by transfected mammalian or insect cells. Individuals autoantibodies identify the TPO ectodomain to the same degree as the holoenzyme. Although small crystals have been from purified TPO, these crystals have not, as yet, offered x-ray diffraction data of adequate resolution to elucidate the three-dimensional structure of the molecule. However, a reasonable image of the TPO ectodomain can be predicted from your crystal data for myeloperoxidase (5) (Number ?(Figure1),1), a closely related molecule with relatively standard amino acid homology (about 47%). Open in a separate window Number 1 Schematic representation of the TSHR with its large (397?amino acid residue without transmission peptide) ectodomain, (3-Carboxypropyl)trimethylammonium chloride seven membrane-spanning segments, and short cytoplasmic tail. TSHR intramolecular cleavage into A and B subunits is definitely associated with the loss of a C peptide region that corresponds approximately to a 50?amino acid insertion in the TSHR absent in the noncleaving LH and FSH receptors. The C peptide region is not eliminated intact. Following cleavage at upstream Site 1, the C peptide is definitely rapidly degraded downstream to the Site 2 region. Evidence suggests that N-terminal degradation of the B subunit continues thereafter, leading to loss of the Cys residues tethering the A subunit and to shedding of the second option. The Cys-rich N-terminus of the A subunit is an important component of thyroid-stimulating autoantibodies and is likely to consist of two disulfide bonds (hypothetically demonstrated by dotted lines) contributing to a conformationally important portion of the molecule. The TSHR, a member of the G protein?coupled receptor family with seven membrane-spanning segments, is definitely closely related to the receptors for the additional glycoprotein hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (examined in ref. 3). Actually before its molecular cloning, the TSHR was known to consist of two subunits, an extracellular A subunit and a mainly transmembrane B subunit, linked by disulfide bonds (6). Translation of both subunits from a single mRNA varieties indicated the TSHR forms by intramolecular cleavage from a larger precursor. Cleavage happens in the mature receptor after it reaches the cell surface (7). Recently, TSHR cleavage into A and B subunits has been found to be associated with the loss of an intervening C peptide section corresponding approximately to a 50?amino acid insertion uniquely present in the TSHR and not present in the noncleaving LH and FSH receptors (8). The C peptide does not look like released intact but is likely to be eliminated in small segments after cleavage at upstream Site 1 terminating at downstream Site 2 (Number ?(Figure2).2). The precise TSHR cleavage sites have not been identified because the unknown enzyme responsible.